Overview

Xolair Treatment for Milk Allergic Children

Status:
Completed
Trial end date:
2017-04-01
Target enrollment:
Participant gender:
Summary
This is a pilot feasibility study, using Xolair pretreatment for oral milk desensitization. The major assessment will be safety, and the investigators will evaluate for any type of reaction, including allergic reactions that occur during the course of the study.
Phase:
Early Phase 1
Details
Lead Sponsor:
Boston Children's Hospital
Boston Children’s Hospital
Collaborator:
Stanford University
Treatments:
Omalizumab